Latest Regulatory News

Xero Limited has agreed to acquire Melio Limited, a leading US SMB bill pay platform, for US$2.5 billion, marking a significant leap in its US growth strategy. The deal is backed by a substantial A$1.85 billion equity raise and aims to accelerate revenue and market presence by FY28.

Treasury Wine Estates has secured Supreme Court approval for a $65 million settlement of a consolidated shareholder class action, allowing the company to focus on its strategic goals without admitting liability.

BlinkLab Limited has responded to an ASX query regarding recent unusual trading activity, confirming no undisclosed material information exists and highlighting pending ADHD diagnostic results expected later this year.

Eildon Capital has launched a new Dividend and Distribution Reinvestment Plan (DRP) offering Australian and New Zealand securityholders a cost-free way to reinvest distributions into additional stapled securities. The plan provides flexible participation options and detailed governance to support investor choice and capital growth.

DTI Group has successfully closed a fully underwritten entitlement offer, raising $2.69 million to support its transit technology ambitions. The offer saw strong shareholder participation alongside a managed shortfall placement.

Adherium Limited has announced an accelerated non-renounceable entitlement offer to raise approximately A$4 million, issuing new shares and options to fund expansion and product development. The offer includes a Top-Up Facility and is partially underwritten, signaling a strategic push to scale its respiratory monitoring technology.

Bastion Mining has surpassed the critical 50.1% ownership threshold in Xanadu Mines, removing key conditions from its takeover bid and declaring the offer unconditional.

Fortifai Limited has successfully raised $2.3 million through an upsized share placement, aiming to bolster its AI Gaming Lab and technology partnerships. The capital injection will support ongoing operations and strategic growth initiatives.

North Stawell Minerals has completed a $1 million placement, issuing over 33 million shares to fund its exploration efforts in Victoria's Stawell Mineralised Corridor.

Cyprium Metals has obtained crucial environmental and operational approvals to advance the phased redevelopment of its Nifty Copper Complex, setting the stage for a near-term production restart.

Radiopharm Theranostics has inked a clinical supply agreement with Cyclotek to support its Phase 1 trial of RAD 402, a novel radiotherapeutic targeting prostate cancer, set to commence in Australia in late 2025.

Meridian Energy has won shareholder approval to acquire NZ Windfarms, paving the way for a landmark repowering of the Te Rere Hau wind farm that could multiply renewable output sevenfold.